Targeted competitive intelligence for pharma and biotech teams — scoped to your indication, not the entire industry. Always-on. Expert-curated.
You're paying $100k+ for a platform you use 10% of — built for breadth, not depth.
Citeline, GlobalData, and Evaluate charge $50–200k/yr for databases built for enterprises with 50-person CI teams. Your team doesn't have that.
By the time a landscape report reaches your desk, a competitor has moved. Phase 3 readouts, FDA filings, and new entrants don't wait for your quarterly review.
You need intelligence on ATTR amyloidosis or HIF-2α inhibitors in ccRCC — not a 300-page report covering every therapeutic area on the planet.
We configure everything around your indication. You receive intelligence, not noise.
Tell us your therapeutic area and key assets. We map every competitor — clinical, commercial, and emerging — in your specific space.
Drawing from ClinicalTrials.gov, SEC filings, conference programs, and proprietary data sources to build a complete, current picture.
Trial status changes, new entrants, regulatory filings, conference abstracts — you're alerted when something actually matters.
Clean, structured intelligence on your schedule. No dashboards to maintain, no noise to filter, no analyst hours wasted.
Every engagement is configured around your specific competitive landscape — nothing generic.
One-time deep dive
Ongoing monitoring + regular updates
Pre- and post-conference briefings
You don't have a 10-person CI department. You have two analysts and a board meeting next month. We're built for that.
Tell us your indication and we'll send you a custom sample landscape within 48 hours. No pitch call. No credit card.
We'll have your custom indication landscape in your inbox within 48 hours. Keep an eye out — it'll be worth the wait.
No sales calls. No credit card. Just the intelligence.